Literature DB >> 8406363

Regulation of iron metabolism in HepG2 cells: a possible role for cytokines in the hepatic deposition of iron.

M Hirayama1, Y Kohgo, H Kondo, N Shintani, K Fujikawa, K Sasaki, J Kato, Y Niitsu.   

Abstract

In chronic inflammation it is reported that serum iron is depleted and hepatic iron is increased because of reticuloendothelial system iron blockade. However, recent studies indicate that hepatic parenchymal cells increase the uptake of transferrin-bound iron after in vivo stimulation with bacterial lipopolysaccharide, suggesting that endotoxemia itself or lipopolysaccharide-induced production of inflammation-related cytokines may also be responsible for this phenomenon. In this study the actions of inflammation-related cytokines on the synthesis of iron-binding proteins (transferrin and ferritin) and transferrin receptor and the uptake of transferrin-bound iron were investigated in a human hepatoblastoma cell line, HepG2, which is the most commonly used cell line for examining the regulation of hepatic protein synthesis by cytokines. The cells were exposed to interleukin-1 beta, interleukin-6 or tumor necrosis factor-alpha separately for 24 hr. In each cytokine treatment group, the level of transferrin, which is secreted into the conditioned medium, was found to be decreased compared with that of untreated cells. On the other hand, the biosynthesis of ferritin was markedly elevated after the same treatment. This increase in ferritin by cytokine treatment was diminished when deferoxamine was used concomitantly to deplete intracellular chelatable iron. After stimulation with interleukin-1 beta, interleukin-6 or tumor necrosis factor-alpha, 59Fe-labeled transferrin uptake into the cells was increased by 36%, 48%, or 18%, respectively, and this uptake was inhibited by the addition of excess unlabeled transferrin. A binding study with 125I-labeled diferric transferrin revealed that the three cytokines increased the number of transferrin receptors on the cell surface by 1.15-fold to 1.35-fold.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8406363     DOI: 10.1002/hep.1840180420

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  23 in total

1.  Clinical analysis of primary Sjögren's syndrome complicating anemia.

Authors:  Jing-Guo Zhou; Yu-Feng Qing; Li Jiang; Qi-Bin Yang; Wen-Feng Luo
Journal:  Clin Rheumatol       Date:  2010-02-20       Impact factor: 2.980

2.  Anaemia in systemic lupus erythematosus: aetiological profile and the role of erythropoietin.

Authors:  M Voulgarelis; S I Kokori; J P Ioannidis; A G Tzioufas; D Kyriaki; H M Moutsopoulos
Journal:  Ann Rheum Dis       Date:  2000-03       Impact factor: 19.103

Review 3.  Prevention of hepatocellular carcinoma: Focusing on antioxidant therapy.

Authors:  Koji Miyanishi; Toshifumi Hoki; Shingo Tanaka; Junji Kato
Journal:  World J Hepatol       Date:  2015-03-27

Review 4.  Transferrin receptor in tissue and serum: updated clinical significance of soluble receptor.

Authors:  Yutaka Kohgo; Yoshihiro Torimoto; Junji Kato
Journal:  Int J Hematol       Date:  2002-10       Impact factor: 2.490

5.  ZRT/IRT-like protein 14 (ZIP14) promotes the cellular assimilation of iron from transferrin.

Authors:  Ningning Zhao; Junwei Gao; Caroline A Enns; Mitchell D Knutson
Journal:  J Biol Chem       Date:  2010-08-03       Impact factor: 5.157

6.  Determinants of serum ALT normalization after phlebotomy in patients with chronic hepatitis C infection.

Authors:  Yusuke Kawamura; Norio Akuta; Hitomi Sezaki; Tetsuya Hosaka; Takashi Someya; Masahiro Kobayashi; Fumitaka Suzuki; Yoshiyuki Suzuki; Satoshi Saitoh; Yasuji Arase; Kenji Ikeda; Hiromitsu Kumada
Journal:  J Gastroenterol       Date:  2005-09       Impact factor: 7.527

7.  Phosphorylation of I kappa B alpha precedes but is not sufficient for its dissociation from NF-kappa B.

Authors:  J A DiDonato; F Mercurio; M Karin
Journal:  Mol Cell Biol       Date:  1995-03       Impact factor: 4.272

8.  The effects of iron deficiency on lymphocyte cytokine production and activation: preservation of hepatic iron but not at all cost.

Authors:  J Jason; L K Archibald; O C Nwanyanwu; M Bell; R J Jensen; E Gunter; I Buchanan; J Larned; P N Kazembe; H Dobbie; W R Jarvis
Journal:  Clin Exp Immunol       Date:  2001-12       Impact factor: 4.330

9.  Cationic polybutyl cyanoacrylate nanoparticles for DNA delivery.

Authors:  Jinghua Duan; Yangde Zhang; Wei Chen; Chengrong Shen; Mingmei Liao; Yifeng Pan; Jiwei Wang; Xingming Deng; Jinfeng Zhao
Journal:  J Biomed Biotechnol       Date:  2009-03-11

10.  Body iron stores and glucose intolerance in premenopausal women: role of hyperandrogenism, insulin resistance, and genomic variants related to inflammation, oxidative stress, and iron metabolism.

Authors:  M Angeles Martínez-García; Manuel Luque-Ramírez; José L San-Millán; Héctor F Escobar-Morreale
Journal:  Diabetes Care       Date:  2009-04-28       Impact factor: 17.152

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.